Like a delivery driver navigating crowded city streets, a gene-therapy-toting lipid nanoparticle faces a gauntlet of potential detours on its journey toward a cell's nucleus. First, there's entering the cell's plasma membrane; then navigating around organelles like the Golgi apparatus, mitochondria and endoplasmic reticulum—all destinations that can errantly absorb the particle's payload, rendering it ineffective at best or harmful at worst. And that's all before the particle even enters the nucleus and successfully makes a genetic change.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Выявлен набор из шести генов, мешающих редактировать геном человека | 0 | 14.55 | 13-08-2026 |
| 2 | Scientists discover why ozempic may not work for some people | 0 | 9.2 | 05-06-2026 |
| 3 | STAT+: Skylar Bio kicks off new gene therapy trial for deafness | 0 | 7.72 | 11-08-2026 |
| 4 | Combined nanoparticle and internal laser method could make cancer therapy less invasive | 0 | 7.19 | 22-07-2026 |
| 5 | STAT+: The quest to save Grace — and clear the way for rare disease patients everywhere | 7 | 8 | 09-07-2026 |
| 6 | STAT+: The promise of radiopharmaceuticals smacks into safety concerns | 0 | 7.74 | 10-08-2026 |
| 7 | Helical nanoparticles trigger cancer alarms and deliver gene therapy | 0 | 5.41 | 28-07-2026 |
| 8 | A grad student’s wild idea sparks a major aging breakthrough | 0 | 7.07 | 15-05-2026 |
| 9 | FDA approves gene therapy for children with sickle cell disease ages 2+ | 5 | 7 | 09-07-2026 |